The brokerage retained Buy on the stock with a revised target price of Rs1,476 on the back of lower multiple to O2C given the weakness in GRM and petrochemical spreads.
Reliance Industries delivered a robust performance in Q3 FY25 beats our Ebitda/PAT estimates by 5.5%/5.9% owing to a stronger-than-expected profit from the retail and oil-to-chemical businesses.
(Source: Company website)
Reliance’s O2C segment showcased steady performance rising 2.4% YoY/16% QoQ due to higher gross refining margin and better PP/PVS spread, partially offset by weaker polyester chain cracks.